Research Output per year
Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Hematologic Malignancies is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Cyclin-Dependent Kinases
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia
Medicine & Life Sciences
Apoptosis
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation
Medicine & Life Sciences
Hodgkin Disease
Medicine & Life Sciences
aprepitant
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Rajat Bannerji
- Cancer Institute of New Jersey (CINJ), Hematologic Malignancies - ASSOC PROF-CLIN-DIV CHIEF
- Clinical Investigations and Precision Therapeutics Program, CINJ - ASSOCIATE MEMBER
Person
Research Output 1990 2019
Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma
Passero, F. C., Ravi, D., McDonald, J. T., Beheshti, A., David, K. & Evens, A., Jan 1 2019, (Accepted/In press) In : British Journal of Haematology.Research output: Contribution to journal › Article
T-Cell Lymphoma
Hodgkin Disease
Apoptosis
Therapeutics
Jurkat Cells
Does Q fever contribute to pathogenesis of non-Hodgkin lymphoma?
David, K., Kritharis, A. & Evens, A., May 1 2018, In : The Lancet Haematology. 5, 5, p. e186-e187Research output: Contribution to journal › Comment/debate
Prognostic factors for complete response to ibrutinib in patients with chronic lymphocytic leukemia: A pooled analysis of 2 clinical trials
O’Brien, S. M., Jaglowski, S., Byrd, J. C., Bannerji, R., Blum, K. A., Fox, C. P., Furman, R. R., Hillmen, P., Kipps, T. J., Montillo, M., Sharman, J., Suzuki, S., James, D. F., Chu, A. D. & Coutre, S. E., May 1 2018, In : JAMA Oncology. 4, 5, p. 712-716 5 p.Research output: Contribution to journal › Article
B-Cell Chronic Lymphocytic Leukemia
Clinical Trials
Therapeutics
Lymph Nodes
Odds Ratio
Press/Media
Combination immune therapy shows promise against Hodgkin lymphoma 6 Dec 2016
12/6/16
9 items of Media coverage
Press/Media: Press / Media
Appointments, Resignations, Deaths (1/15/2016)
1/10/16
1 item of Media coverage
Press/Media: Press / Media